Daily non-political popular news in brief.
Molecular signature may identify cisplatin-sensitive breast tumors
04-19-2007 · EurekAlert!Researchers at the Massachusetts General Hospital Cancer Center have identified a subgroup of hard-to-treat breast cancers that may be sensitive to the drug cisplatin, rarely used in the treatment of breast tumors. They also have discovered the molecular basis of this sensitivity, which may help identify patients most likely to benefit from cisplatin treatment.
Read more »
Keywords: molecular, signature, identify, cisplatin-sensitive, breast, tumors, cisplatin, sensitive, tumor
« Previous | Next »
Similar news on "Molecular signature may identify cisplatin-sensitive breast tumors":
- Genetic fingerprints identify brain tumors' origins
02-01-2007 · EurekAlert!
Genetic fingerprints that reveal where a brain cell came from remain distinct even after the cell becomes a brain tumor, an international coalition of scientists will report in the Feb. 1 issue of Cancer Research.
Similar news · Read more »
- Tumor vessels identified by unique molecular markers
06-11-2007 · EurekAlert!
Results from a new study have made it easier for scientists to distinguish between growing blood vessels in healthy tissues and those that are associated with tumors. This is a significant finding because this distinction, particularly at a molecular level, has remained elusive for quite some time. The research, released in the June issue of the journal Cancer Cell, published by Cell Press, has exciting implications for development of more selective vascular-targeted anticancer therapeutics.
Similar news · Read more »
- Researchers identify unusual molecular switch for common form of advanced breast cancer
11-08-2007 · EurekAlert!
New evidence demonstrates that a novel molecular switch is involved in the development of a common form of advanced breast cancer, known as locally advanced breast cancer. The research, published by Cell Press in the Nov. 9, 2007 issue of Molecular Cell, provides an exciting paradigm shift in the understanding of a key event in breast cancer development and presents new therapeutic opportunities for this deadly disease.
Similar news · Read more »
- Why cisplatin kills breast cancer cells when other drugs fail
04-19-2007 · EurekAlert!
The cancerous cells of some individuals with breast cancer lack expression of two cell surface proteins, the estrogen and progesterone receptors, and do not express increased amounts of HER2. Individuals with such breast cancer (known as triple-negative breast cancer) do not respond to treatment with commonly used chemotherapeutic drugs and their prognosis is relatively poor. But a new study has indicated why triple-negative breast cancer cell lines are sensitive to exposure to the chemotherapeutic cisplatin.
Similar news · Read more »
- UT Health Science Center researchers decoding saliva to detect breast cancer
01-10-2008 · EurekAlert!
Researchers at The University of Texas Health Science Center at Houston can identify and quantify specific protein markers in human saliva to provide an early, non-invasive diagnosis of breast cancer, according to a study appearing today in the journal Cancer Investigation. The study is being applied to "lab-on-a-chip" technology that may bring this type of diagnostic test -- capable of detecting the presence of cancer before a tumor forms -- into everyday use.
Similar news · Read more »
- U-M researchers identify stem cells in pancreatic cancer
02-01-2007 · EurekAlert!
University of Michigan Comprehensive Cancer Center researchers have discovered the small number of cells in pancreatic cancer that are capable of fueling the tumor's growth. The finding is the first identification of cancer stem cells in pancreatic tumors.
Similar news · Read more »
- Treatment capitalizes on unique qualities of radioisotope to prolong lives of brain tumor patients
01-30-2008 · EurekAlert!
In a study to determine safe dosages of the isotope astatine-211 for patients with recurring brain tumors, researchers were pleasantly surprised to find that not only was the isotope's potency sufficient to kill residual cancer cells without damaging sensitive healthy brain cells, but the patients experienced longer survival rates.
Similar news · Read more »
- Cell response to stress signals predicts tumors in women with common pre-breast cancer
11-12-2007 · EurekAlert!
A specific biological response to cellular stress may predict the likelihood of future tumor formation of the most common, noninvasive form of pre-malignant breast cancer -- ductal carcinoma in situ, or DCIS.
Similar news · Read more »
- Biomarkers predict risk for invasive breast cancer years before the tumor develops
11-12-2007 · EurekAlert!
A team of scientists from the University of California San Francisco has identified distinct molecular markers that predict whether or not a woman is likely to develop subsequent invasive cancer after initial diagnosis with a noninvasive form of early breast cancer. The research, published by Cell Press in the November issue of Cancer Cell, provides critical information that can be used to determine whether a woman should receive more or less aggressive therapy.
Similar news · Read more »
- Researchers identify genes that allow brain cancer-causing stem cells to resist treatment
12-14-2006 · EurekAlert!
Researchers at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute, who first isolated cancer stem cells in adult brain tumors in 2004, have now found these cells to be highly resistant to chemotherapy and other treatments. Even if a tumor is almost completely obliterated, it will regenerate from the surviving cancer stem cells and be even more resistant to treatment than before.
Similar news · Read more »
